Risk of HCV Infection in Haemophiliacs Treated with a Dry-Heated Factor VIII Concentrate

• References

• 1 Ebeling F, Rasi V, Naukkarinen R, Leikola J. Antibodies to hepatitic C virus and chronic liver disease among Finnish patients with haemophilia. Ann Med 1991; 22: 393-396
• 2 Prince AM, Horowitch B. Virus-free labile blood derivates. In: Treatment of Haemophilia and von Willebrand’s Disease: New Developments. American Association of Blood Banks; Arlington, VA: 1989
• 3 Tabor E, Purcell R, Gerety R. Primate animal models and titared inocula for the study of hepatitis A, hepatitis B and non-A, non-B hepatitis. J Med Primatol 1984; 12: 305-318
• 4 van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, di Nello R, van Boven JJP, Winkel I, Mulder-Folkerts D, Exel-Oehlers PJ, Schaasberg W, Leentvaar-Kuypers A, Polito A, Houghton M, Lelie PN. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991; 337: 317-319
• 5 Alter HJ, Purcell RH, Rhih JW. et al Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494-1500